Also, glycemic improvements by EMPA were associated with reductions in vascular oxidative stress, advanced glycation end-products (AGE) and their receptor (RAGE) interaction, low-grade chronic inflammation and vascular dysfunction in the rat ZDF-Lepr (fa/fa) (leptin receptor deficient) rodent model of diabetes [19]. Here, LEPR is linked to diabetes mellitus.